Calmodulin enhances mTORC1 signaling by preventing TSC2-Rheb binding
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2024.108122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Yuna Amemiya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan. Hauptthemen laut MEDLINE: Calmodulin, Tuberous Sclerosis Complex 2 Protein, Mechanistic Target of Rapamycin Complex 1, Ras Homolog Enriched in Brain Protein. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The mechanistic target of rapamycin complex 1 (mTORC1) functions as a master regulator of cell growth and proliferation. We previously demonstrated that intracellular calcium ion (Ca2+) concentration modulates the mTORC1 pathway via binding of the Ca2+ sensor protein calmodulin (CaM) to tuberous sclerosis complex 2 (TSC2), a critical negative regulator of mTORC1. However, the precise molecular mechanism by which Ca2+/CaM modulates mTORC1 activity remains unclear. Here, we performed a binding assay based on nano-luciferase reconstitution, a method for detecting weak interactions between TSC2 and its target, Ras homolog enriched in the brain (Rheb), an activator of mTORC1. CaM inhibited the binding of TSC2 to Rheb in a Ca2+-dependent manner. Live-cell imaging analysis indicated increased interaction between the CaM-binding region of TSC2 and CaM in response to elevated intracellular Ca2+ levels. Furthermore, treatment with carbachol, an acetylcholine analog, elevated intracellular Ca2+ levels and activated mTORC1. Notably, carbachol-induced activation of mTORC1 was inhibited by CaM inhibitors, corroborating the role of Ca2+/CaM in promoting the mTORC1 pathway. Consistent with the effect of Ca2+/CaM on the TSC2-Rheb interaction, increased intracellular Ca2+ concentration promoted the dissociation of TSC2 from lysosomes without affecting Akt-dependent phosphorylation of TSC2, suggesting that the regulatory mechanism of TSC2 by Ca2+/CaM is distinct from the previously established action mechanism of TSC2. Collectively, our findings offer mechanistic insights into TSC2-Rheb regulation mediated by Ca2+/CaM, which links Ca2+ signaling to mTORC1 activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
- Department of Biochemistry, Meiji Pharmaceutical University, Tokyo, Japan.
- Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan. Electronic address: takahara@agr.nagoya-u.ac.jp.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Amemiya, Y., Ioi, Y., Araki, M., Kontani, K., Maki, M., Shibata, H., & Takahara, T. (2025). Calmodulin enhances mTORC1 signaling by preventing TSC2-Rheb binding. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.108122
Vancouver
Amemiya Y, Ioi Y, Araki M, Kontani K, Maki M, Shibata H, et al. Calmodulin enhances mTORC1 signaling by preventing TSC2-Rheb binding. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2024.108122
BibTeX
@article{Amemiya2025,
author = {Amemiya, Yuna and Ioi, Yuichiro and Araki, Makoto and Kontani, Kenji and Maki, Masatoshi and Shibata, Hideki and Takahara, Terunao},
title = {Calmodulin enhances mTORC1 signaling by preventing TSC2-Rheb binding},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2024.108122}
}
EUVIMED